<DOC>
	<DOCNO>NCT01639495</DOCNO>
	<brief_summary>This prospective , multicenter , non-randomized continued access clinical evaluation utilize THERMOCOOL® SMARTTOUCH™ catheter .</brief_summary>
	<brief_title>THERMOCOOL® SMARTTOUCH™ Catheter Treatment Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS</brief_title>
	<detailed_description>The device currently investigation IDE # G110030 . This continue access study enroll subject participate Smart-AF IDE study . Subjects drug refractory symptomatic paroxysmal atrial fibrillation ( PAF ) consider study . Effectiveness safety endpoint define evaluated post treatment .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Have least 3 atrial fibrillation episode within 6 month study Have fail least one antiarrhythmic drug show repeat atrial fibrillation episodes 18 year age old Exclusion Criteria include , limited : Have previous ablation atrial fibrillation Have take amiodarone within 6 month study Have heart surgery within last 60 day Have heart attack within last 60 day Females pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Drug refractory</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Antiarrhythmic drug failure</keyword>
	<keyword>Atrial tachyarrhythmias</keyword>
</DOC>